Join
Live feed
·
SECFilingvia Quantisnow
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure

ByQuantisnow·Wall Street's wire, on your screen.
EBS· Emergent BioSolutions Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBS (Emergent BioSolutions Inc.) and more on Quantisnow.

Emergent BioSolutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure | Quantisnow